Anti BCMA CAR-T cells therapy (Minsk Scientific-Practical Center For Surgery, Transplantation And Hematology)

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameAnti BCMA CAR-T cells therapy (Minsk Scientific-Practical Center For Surgery, Transplantation And Hematology)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsAnti-BCMA

TargetsB-cell maturation protein

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelarus

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMinsk Scientific-Practical Center For Surgery, Transplantation And Hematology

China Registration ClassN/A

Develop Information

Active CompaniesMinsk Scientific-Practical Center For Surgery, Transplantation And Hematology

Inactive CompaniesN/A

Active IndicationsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A